EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Imipramine Inhibits Osteosarcoma Invasion via Src Inactivation and Caspase‐Dependent Apoptosis

Yu-Chang Liu iD, Chi-Jung Fang, Li-Cho Hsu, Fei-Ting Hsu iD, Ming-Hsien Hu

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Yu-Chang Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, ROC. Hauptthemen laut MEDLINE: Imipramine, Apoptosis, Osteosarcoma, Caspases. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taipei, Taiwan, An Nan Hospital, China Medical University, National Yang-Ming Chiao-Tung University Hospital, Yilian, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is an aggressive malignancy characterised by high metastatic potential and poor prognosis. Imipramine, a tricyclic antidepressant, has shown potential anticancer effects. This study evaluates the cytotoxic, pro‐apoptotic and anti‐invasion effects of imipramine on OS cells in vitro and in vivo, as well as its underlying mechanisms. Imipramine significantly reduced U‐2 OS and MG 63 cell viability in a time‐ and dose‐dependent manner, confirmed through MTT and colony formation assays. It induced apoptosis via caspase‐dependent pathways, as evidenced by increased cleaved caspase‐3, ‐8 and ‐9 levels and reduced expression of anti‐apoptotic proteins such as MCL‐1. Imipramine activated both extrinsic and intrinsic apoptosis pathways in vitro and in vivo, increasing Fas, Fas‐L, BAX and BAK while suppressing anti‐apoptotic factors like BCL‐2 and XIAP. Transwell assays showed dose‐dependent inhibition of cell migration and invasion, supported by suppressed Src phosphorylation and downregulation of EMT markers (Snail‐1 and Slug). In U‐2 OS xenograft‐bearing mice, imipramine significantly inhibited tumour growth in a dose‐dependent manner, with the 30 mg/kg group showing the smallest tumour volume and slowest growth rate ( p = 0.0098). Tumour weights were significantly reduced without impacting body weight or liver and kidney function markers (AST, ALT, γ‐GT and CREA). Histopathological analyses revealed no significant abnormalities in vital organs. Imipramine exerts potent anti‐OS effects by suppressing Src‐mediated invasion and enhancing caspase‐dependent apoptosis through extrinsic and intrinsic pathways. It inhibits tumour progression without inducing systemic toxicity, demonstrating its potential as a therapeutic candidate for OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImipramineApoptosisOsteosarcomaCaspasessrc-Family KinasesBone NeoplasmsHumansAnimalsCell Line, TumorCell MovementXenograft Model Antitumor AssaysNeoplasm InvasivenessMiceCell ProliferationMice, NudeCell SurvivalMice, Inbred BALB CEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

Srcapoptosisimipramineinvasionosteosarcoma

Substanzen

ImipramineCaspasessrc-Family Kinases

Autor:innen und Institutionen

  • Department of Radiation Oncology, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, ROC.
  • Department of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology, Taichung, Taiwan, ROC.
  • Department of Orthopaedic Surgery, An Nan Hospital, China Medical University, Tainan, Taiwan, ROC.
  • Department of Medicine, National Yang-Ming Chiao-Tung University Hospital, Yilan, Taiwan, ROC.
  • Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, ROC.
  • Department of Life Sciences, National Central University, Taoyuan, Taiwan, ROC.

ORCID-Profile: Yu-Chang Liu, Fei-Ting Hsu

Förderung

  • National Science and Technology Council, Taipei, Taiwan
  • An Nan Hospital, China Medical University
  • National Yang-Ming Chiao-Tung University Hospital, Yilian, Taiwan
  • Chang Bing Show Chwan Memorial Hospital
  • Ministry of Education, Taiwan
  • Tainan Municipal An-Nan Hospital

Zitieren

APA

Liu, Y. C., Fang, C. J., Hsu, L. C., Hsu, F. T., & Hu, M. H. (2025). Imipramine Inhibits Osteosarcoma Invasion via Src Inactivation and Caspase‐Dependent Apoptosis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70761

Vancouver

Liu YC, Fang CJ, Hsu LC, Hsu FT, Hu MH. Imipramine Inhibits Osteosarcoma Invasion via Src Inactivation and Caspase‐Dependent Apoptosis. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70761

BibTeX
@article{Liu2025,
  author = {Liu, Yu-Chang and Fang, Chi-Jung and Hsu, Li-Cho and Hsu, Fei-Ting and Hu, Ming-Hsien},
  title = {Imipramine Inhibits Osteosarcoma Invasion via Src Inactivation and Caspase‐Dependent Apoptosis},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70761}
}
Kostenlos starten →